Protalix BioTherapeutics
PLX
PLX
44 hedge funds and large institutions have $59.3M invested in Protalix BioTherapeutics in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
29% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 14
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $147K
Holders
44
Holding in Top 10
–
Calls
$1K
Puts
$147K
Top Buyers
| 1 | +$1.07M | |
| 2 | +$392K | |
| 3 | +$180K | |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$176K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$162K |
Top Sellers
| 1 | -$466K | |
| 2 | -$388K | |
| 3 | -$354K | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$331K |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$275K |